AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and University of Maryland at Baltimore . Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. We are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.
Company Details
- Employees
- 7
- Founded
- -
- Address
- One Rockefeller Plaza, 11th Floor, New York,ny 10020,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ir.aikidopharma.com/
- Keywords
- Oncology and Biopharmaceuticals.
- HQ
- New York, NY
Aikido Pharma Inc Questions
Aikido Pharma Inc's website is https://ir.aikidopharma.com/
Aikido Pharma Inc's LinkedIn profile is https://www.linkedin.com/company/aikidopharma
Aikido Pharma Inc has
7 employees.
View email and phone details for 7
employees at Aikido Pharma Inc.
Aikido Pharma Inc's industry is
Biotechnology Research
Aikido Pharma Inc's top competitors are
Royalty Pharma,
Inventiva Pharma,
A2a Pharmaceuticals,
Aethon Therapeutics,
Dominari Securities,
Dominari Holdings,
Global Alliant Inc,
Aim Immunotech,
Oviva Therapeutics,
New York Genome Center.
Aikido Pharma Inc's categories are Biotechnology Research
Aikido Pharma Inc's founding year is 1967
